Table 4.

Multivariable-Adjusted OR (95% CI) for Worsening FP Associated With Baseline Endocrine Predictors

Models and Adjustments
Baseline ParameterNModel 1 Baseline Frailty
Model 2 Baseline Frailty and Age
Model 3 Baseline Frailty, Age, Center, Smoking
Model 4 Baseline Frailty, Age, Center, Smoking, BMIc
OR95% CIP ValueOR95% CIP ValueOR95% CIP ValueOR95% CIP Value
Total T17661.040.93, 1.160.4461.040.93, 1.160.5201.080.96, 1.220.1871.050.92, 1.180.474
fT17600.860.77, 0.960.0080.980.87, 1.10.7021.030.91, 1.160.6810.990.88, 0.040.979
DHT17591.070.96, 1.190.2131.030.92, 1.150.6011.010.90, 1.140.8220.960.85, 1.090.574
E2a17591.040.94, 1.160.4350.990.87, 1.130.8941.070.94, 1.230.3001.110.97, 1.280.136
SHBG17691.251.12, 1.39<0.0011.080.96, 1.220.1811.100.97, 1.240.1441.060.94, 1.210.342
FSH17681.211.09, 1.34<0.0011.090.98, 1.220.1231.110.99, 1.240.0851.100.98, 1.240.094
LH17671.201.08, 1.330.0011.090.97, 1.220.1321.080.96, 0.210.1831.070.95, 1.200.257
Models and Adjustments
Baseline ParameterNModel 1 Baseline Frailty
Model 2 Baseline Frailty and Age
Model 3 Baseline Frailty, Age, Center, Smoking
Model 4 Baseline Frailty, Age, Center, Smoking, BMIc
OR95% CIP ValueOR95% CIP ValueOR95% CIP ValueOR95% CIP Value
Total T17661.040.93, 1.160.4461.040.93, 1.160.5201.080.96, 1.220.1871.050.92, 1.180.474
fT17600.860.77, 0.960.0080.980.87, 1.10.7021.030.91, 1.160.6810.990.88, 0.040.979
DHT17591.070.96, 1.190.2131.030.92, 1.150.6011.010.90, 1.140.8220.960.85, 1.090.574
E2a17591.040.94, 1.160.4350.990.87, 1.130.8941.070.94, 1.230.3001.110.97, 1.280.136
SHBG17691.251.12, 1.39<0.0011.080.96, 1.220.1811.100.97, 1.240.1441.060.94, 1.210.342
FSH17681.211.09, 1.34<0.0011.090.98, 1.220.1231.110.99, 1.240.0851.100.98, 1.240.094
LH17671.201.08, 1.330.0011.090.97, 1.220.1321.080.96, 0.210.1831.070.95, 1.200.257

Abbreviations: BMIc, BMI categories (<25, 25 to 30, ≥30); DM, diabetes mellitus; N, sample size.

a

Models 2 to 4 additionally adjusted for baseline total T level.

Table 4.

Multivariable-Adjusted OR (95% CI) for Worsening FP Associated With Baseline Endocrine Predictors

Models and Adjustments
Baseline ParameterNModel 1 Baseline Frailty
Model 2 Baseline Frailty and Age
Model 3 Baseline Frailty, Age, Center, Smoking
Model 4 Baseline Frailty, Age, Center, Smoking, BMIc
OR95% CIP ValueOR95% CIP ValueOR95% CIP ValueOR95% CIP Value
Total T17661.040.93, 1.160.4461.040.93, 1.160.5201.080.96, 1.220.1871.050.92, 1.180.474
fT17600.860.77, 0.960.0080.980.87, 1.10.7021.030.91, 1.160.6810.990.88, 0.040.979
DHT17591.070.96, 1.190.2131.030.92, 1.150.6011.010.90, 1.140.8220.960.85, 1.090.574
E2a17591.040.94, 1.160.4350.990.87, 1.130.8941.070.94, 1.230.3001.110.97, 1.280.136
SHBG17691.251.12, 1.39<0.0011.080.96, 1.220.1811.100.97, 1.240.1441.060.94, 1.210.342
FSH17681.211.09, 1.34<0.0011.090.98, 1.220.1231.110.99, 1.240.0851.100.98, 1.240.094
LH17671.201.08, 1.330.0011.090.97, 1.220.1321.080.96, 0.210.1831.070.95, 1.200.257
Models and Adjustments
Baseline ParameterNModel 1 Baseline Frailty
Model 2 Baseline Frailty and Age
Model 3 Baseline Frailty, Age, Center, Smoking
Model 4 Baseline Frailty, Age, Center, Smoking, BMIc
OR95% CIP ValueOR95% CIP ValueOR95% CIP ValueOR95% CIP Value
Total T17661.040.93, 1.160.4461.040.93, 1.160.5201.080.96, 1.220.1871.050.92, 1.180.474
fT17600.860.77, 0.960.0080.980.87, 1.10.7021.030.91, 1.160.6810.990.88, 0.040.979
DHT17591.070.96, 1.190.2131.030.92, 1.150.6011.010.90, 1.140.8220.960.85, 1.090.574
E2a17591.040.94, 1.160.4350.990.87, 1.130.8941.070.94, 1.230.3001.110.97, 1.280.136
SHBG17691.251.12, 1.39<0.0011.080.96, 1.220.1811.100.97, 1.240.1441.060.94, 1.210.342
FSH17681.211.09, 1.34<0.0011.090.98, 1.220.1231.110.99, 1.240.0851.100.98, 1.240.094
LH17671.201.08, 1.330.0011.090.97, 1.220.1321.080.96, 0.210.1831.070.95, 1.200.257

Abbreviations: BMIc, BMI categories (<25, 25 to 30, ≥30); DM, diabetes mellitus; N, sample size.

a

Models 2 to 4 additionally adjusted for baseline total T level.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close